196 related articles for article (PubMed ID: 36126235)
1. Inflammation and Clinical Decline After Adjuvant Chemotherapy in Older Adults With Breast Cancer: Results From the Hurria Older Patients Prospective Study.
Ji J; Sun CL; Cohen HJ; Synold T; Muss H; Sedrak MS
J Clin Oncol; 2023 Jan; 41(2):307-315. PubMed ID: 36126235
[TBL] [Abstract][Full Text] [Related]
2. Toxicity risk score and clinical decline after adjuvant chemotherapy in older breast cancer survivors.
Ji J; Sun CL; Cohen HJ; Muss HB; Bae M; Sedrak MS
J Natl Cancer Inst; 2023 May; 115(5):578-585. PubMed ID: 36762832
[TBL] [Abstract][Full Text] [Related]
3. The impact of adjuvant chemotherapy in older breast cancer patients on clinical and biological aging parameters.
Brouwers B; Hatse S; Dal Lago L; Neven P; Vuylsteke P; Dalmasso B; Debrock G; Van Den Bulck H; Smeets A; Bechter O; Bailur JK; Kenis C; Laenen A; Schöffski P; Pawelec G; Journe F; Ghanem GE; Wildiers H
Oncotarget; 2016 May; 7(21):29977-88. PubMed ID: 27102154
[TBL] [Abstract][Full Text] [Related]
4. Falls prechemotherapy and toxicity-related hospitalization during adjuvant chemotherapy for breast cancer in older women: Results from the prospective multicenter HOPE trial.
Ji J; Bae M; Sun CL; Wildes TM; Freedman RA; Magnuson A; O'Connor T; Moy B; Klepin HD; Chapman AE; Tew WP; Dotan E; Fenton MA; Kim H; Katheria V; Gross CP; Cohen HJ; Muss HB; Sedrak MS
Cancer; 2024 Mar; 130(6):936-946. PubMed ID: 37962093
[TBL] [Abstract][Full Text] [Related]
5. The longitudinal relationship between immune cell profiles and frailty in patients with breast cancer receiving chemotherapy.
Gilmore N; Mohile S; Lei L; Culakova E; Mohamed M; Magnuson A; Loh KP; Maggiore R; Belcher E; Conlin A; Weiselberg L; Ontko M; Janelsins M
Breast Cancer Res; 2021 Feb; 23(1):19. PubMed ID: 33546731
[TBL] [Abstract][Full Text] [Related]
6. Longitudinal Relationship Between Frailty and Cognition in Patients 50 Years and Older with Breast Cancer.
Magnuson A; Lei L; Gilmore N; Kleckner AS; Lin FV; Ferguson R; Hurria A; Wittink MN; Esparaz BT; Giguere JK; Misleh J; Bautista J; Mohile SG; Janelsins MC
J Am Geriatr Soc; 2019 May; 67(5):928-936. PubMed ID: 31034595
[TBL] [Abstract][Full Text] [Related]
7. Frailty and adherence to adjuvant hormonal therapy in older women with breast cancer: CALGB protocol 369901.
Sheppard VB; Faul LA; Luta G; Clapp JD; Yung RL; Wang JH; Kimmick G; Isaacs C; Tallarico M; Barry WT; Pitcher BN; Hudis C; Winer EP; Cohen HJ; Muss HB; Hurria A; Mandelblatt JS
J Clin Oncol; 2014 Aug; 32(22):2318-27. PubMed ID: 24934786
[TBL] [Abstract][Full Text] [Related]
8. Chronic cytomegalovirus infection and inflammation are associated with prevalent frailty in community-dwelling older women.
Schmaltz HN; Fried LP; Xue QL; Walston J; Leng SX; Semba RD
J Am Geriatr Soc; 2005 May; 53(5):747-54. PubMed ID: 15877548
[TBL] [Abstract][Full Text] [Related]
9. Serum Myostatin and IGF-1 as Gender-Specific Biomarkers of Frailty and Low Muscle Mass in Community-Dwelling Older Adults.
Chew J; Tay L; Lim JP; Leung BP; Yeo A; Yew S; Ding YY; Lim WS
J Nutr Health Aging; 2019; 23(10):979-986. PubMed ID: 31781728
[TBL] [Abstract][Full Text] [Related]
10. Is hyperglycemia associated with frailty status in older women?
Blaum CS; Xue QL; Tian J; Semba RD; Fried LP; Walston J
J Am Geriatr Soc; 2009 May; 57(5):840-7. PubMed ID: 19484839
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of pro-inflammatory cytokines in frail Tunisian older adults.
Hammami S; Ghzaiel I; Hammouda S; Sakly N; Hammami M; Zarrouk A
PLoS One; 2020; 15(11):e0242152. PubMed ID: 33166358
[TBL] [Abstract][Full Text] [Related]
12. Self-Reported Frailty Screening Tools: Comparing Construct Validity of the Frailty Phenotype Questionnaire and FRAIL.
Chia JQ; Low K; Chew J; Lim JP; Goh LL; Wansaicheong G; Lim WS
J Am Med Dir Assoc; 2022 Nov; 23(11):1870.e1-1870.e7. PubMed ID: 35660384
[TBL] [Abstract][Full Text] [Related]
13. Endocrine and inflammatory markers as predictors of frailty.
Puts MT; Visser M; Twisk JW; Deeg DJ; Lips P
Clin Endocrinol (Oxf); 2005 Oct; 63(4):403-11. PubMed ID: 16181232
[TBL] [Abstract][Full Text] [Related]
14. Associations between frailty and cancer-specific mortality among older women with breast cancer.
Yan CH; Coleman C; Nabulsi NA; Chiu BC; Ko NY; Hoskins K; Calip GS
Breast Cancer Res Treat; 2021 Oct; 189(3):769-779. PubMed ID: 34241741
[TBL] [Abstract][Full Text] [Related]
15. Physical Functioning in Older Patients With Breast Cancer: A Prospective Cohort Study in the TEAM Trial.
Derks MG; de Glas NA; Bastiaannet E; de Craen AJ; Portielje JE; van de Velde CJ; van Leeuwen FE; Liefers GJ
Oncologist; 2016 Aug; 21(8):946-53. PubMed ID: 27368882
[TBL] [Abstract][Full Text] [Related]
16. Physical Frailty Is Associated with Longitudinal Decline in Global Cognitive Function in Non-Demented Older Adults: A Prospective Study.
Chen S; Honda T; Narazaki K; Chen T; Kishimoto H; Haeuchi Y; Kumagai S
J Nutr Health Aging; 2018; 22(1):82-88. PubMed ID: 29300426
[TBL] [Abstract][Full Text] [Related]
17. Functional Decline and Resilience in Older Women Receiving Adjuvant Chemotherapy for Breast Cancer.
Hurria A; Soto-Perez-de-Celis E; Allred JB; Cohen HJ; Arsenyan A; Ballman K; Le-Rademacher J; Jatoi A; Filo J; Mandelblatt J; Lafky JM; Kimmick G; Klepin HD; Freedman RA; Burstein H; Gralow J; Wolff AC; Magrinat G; Barginear M; Muss H
J Am Geriatr Soc; 2019 May; 67(5):920-927. PubMed ID: 30146695
[TBL] [Abstract][Full Text] [Related]
18. Association of Pre-Chemotherapy Peripheral Blood Pro-Inflammatory and Coagulation Factors with Physical Function in Women with Breast Cancer.
Yuan Y; Vora N; Sun CL; Li D; Smith D; Mortimer J; Luu TH; Somlo G; Waisman J; Chao J; Katheria V; Synold T; Tran V; Mi S; Feng T; Levi A; Arsenyan A; Choi J; Zavala L; Yost S; Hurria A
Oncologist; 2017 Oct; 22(10):1189-1196. PubMed ID: 28559409
[TBL] [Abstract][Full Text] [Related]
19. Association between inflammatory markers and frailty in institutionalized older men.
Lai HY; Chang HT; Lee YL; Hwang SJ
Maturitas; 2014 Nov; 79(3):329-33. PubMed ID: 25132319
[TBL] [Abstract][Full Text] [Related]
20. The risk of febrile neutropenia in breast cancer patients following adjuvant chemotherapy is predicted by the time course of interleukin-6 and C-reactive protein by modelling.
Netterberg I; Karlsson MO; Nielsen EI; Quartino AL; Lindman H; Friberg LE
Br J Clin Pharmacol; 2018 Mar; 84(3):490-500. PubMed ID: 29178353
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
